CVS Health Corporation
General ticker "CVS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $82.7B (TTM average)
CVS Health Corporation follows the US Stock Market performance with the rate: 45.2%.
Estimated limits based on current volatility of 1.5%: low 78.62$, high 81.08$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-10-23, amount 0.67$ (Y3.41%)
- Total employees count: 300000 (0.0%) as of 2024
- Top business risk factors: Economic downturns and volatility, Cybersecurity threats, Healthcare cost pressures, Market competition, Litigation risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [45.85$, 67.68$]
- 2025-12-31 to 2026-12-31 estimated range: [50.76$, 74.26$]
Financial Metrics affecting the CVS estimates:
- Negative: with PPE of 8.2 at the end of fiscal year the price was very high
- Positive: -5.02 < Operating profit margin, % of 2.28
- Positive: Operating cash flow per share per price, % of 16.27 > 12.91
- Positive: Inventory ratio change, % of -0.16 <= 0
- Negative: Investing cash flow per share per price, % of -13.60 <= -4.41
- Positive: -9.48 < Industry operating profit margin (median), % of 1.70
- Negative: 19.35 < Shareholder equity ratio, % of 29.84 <= 42.53
- Negative: Return on assets ratio (scaled to [-100,100]) of 1.78 <= 6.04
Short-term CVS quotes
Relationship graph
Long-term CVS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $316,664.00MM | $357,776.00MM | $372,709.00MM |
| Operating Expenses | $308,710.00MM | $344,033.00MM | $364,193.00MM |
| Operating Income | $7,954.00MM | $13,743.00MM | $8,516.00MM |
| Non-Operating Income | $-2,118.00MM | $-2,570.00MM | $-2,368.00MM |
| Interest Expense | $2,287.00MM | $2,658.00MM | $2,958.00MM |
| Income(Loss) | $5,836.00MM | $11,173.00MM | $6,148.00MM |
| Taxes | $1,509.00MM | $2,805.00MM | $1,562.00MM |
| Profit(Loss)* | $4,311.00MM | $8,344.00MM | $4,614.00MM |
| Stockholders Equity | $71,469.00MM | $76,461.00MM | $75,560.00MM |
| Inventory | $19,090.00MM | $18,025.00MM | $18,107.00MM |
| Assets | $228,275.00MM | $249,728.00MM | $253,215.00MM |
| Operating Cash Flow | $16,177.00MM | $13,426.00MM | $9,107.00MM |
| Capital expenditure | $2,727.00MM | $3,031.00MM | $2,781.00MM |
| Investing Cash Flow | $-5,047.00MM | $-20,889.00MM | $-7,613.00MM |
| Financing Cash Flow | $-10,516.00MM | $2,683.00MM | $-1,135.00MM |
| Earnings Per Share** | $3.29 | $6.49 | $3.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.